Factor VIII-driven changes in activated factor IX explored by hydrogen-deuterium exchange mass spectrometry.

Blood
Nadia FreatoKoen Mertens

Abstract

The assembly of the enzyme-activated factor IX (FIXa) with its cofactor, activated factor VIII (FVIIIa) is a crucial event in the coagulation cascade. The absence or dysfunction of either enzyme or cofactor severely compromises hemostasis and causes hemophilia. FIXa is a notoriously inefficient enzyme that needs FVIIIa to drive its hemostatic potential, by a mechanism that has remained largely elusive to date. In this study, we employed hydrogen-deuterium exchange-mass spectrometry (HDX-MS) to investigate how FIXa responds to assembly with FVIIIa in the presence of phospholipids. This revealed a complex pattern of changes that partially overlaps with those changes that occur upon occupation of the substrate-binding site by an active site-directed inhibitor. Among the changes driven by both cofactor and substrate, HDX-MS highlighted several surface loops that have been implicated in allosteric networks in related coagulation enzymes. Inspection of FVIIIa-specific changes indicated that 3 helices are involved in FIXa-FVIIIa assembly. These are part of a basic interface that is also known as exosite II. Mutagenesis of basic residues herein, followed by functional studies, identified this interface as an extended FVIIIa-interactive...Continue Reading

References

Mar 1, 1980·The Biochemical Journal·K Mertens, R M Bertina
Jan 1, 1980·CRC Critical Reviews in Biochemistry·Y Nemerson, B Furie
Oct 10, 1995·Proceedings of the National Academy of Sciences of the United States of America·H BrandstetterW Bode
Jun 9, 2001·The New England Journal of Medicine·P M Mannucci, E G Tuddenham
Nov 22, 2002·The Journal of Biological Chemistry·Katrin SichlerHans Brandstetter
Jan 30, 2003·Trends in Cardiovascular Medicine·Amy E Schmidt, S Paul Bajaj
Mar 4, 2006·International Journal of Hematology·Philip J Fay
May 12, 2006·The Journal of Biological Chemistry·Kasper D RandMette D Andersen
Oct 23, 2009·The New England Journal of Medicine·Paolo SimioniValder R Arruda
Apr 19, 2011·The International Journal of Biochemistry & Cell Biology·Henriët MeemsAlexander B Meijer
Sep 12, 2012·Journal of the American Society for Mass Spectrometry·Benjamin T WaltersS Walter Englander
Feb 5, 2013·The Journal of Biological Chemistry·Marina V MalovichkoMuriel C Maurer
Jul 23, 2013·Blood·Bernhard C LechtenbergJames A Huntington
May 13, 2014·The Biochemical Journal·Dionysios PantazatosGary E Gilbert
Oct 16, 2015·Biochemistry·Lindsey D HandleyElizabeth A Komives
May 22, 2016·The Biochemical Journal·Line Hyltoft KristensenHans Brandstetter
Apr 11, 2018·Biochemistry·Riley B PeacockElizabeth A Komives
Dec 19, 2018·Biophysical Journal·Phineus R L MarkwickElizabeth A Komives
Sep 29, 2019·Haematologica·Małgorzata A PrzeradzkaAlexander B Meijer

❮ Previous
Next ❯

Citations

Mar 10, 2021·Journal of Thrombosis and Haemostasis : JTH·Nadia FreatoEduard H T M Ebberink
May 29, 2021·Journal of Thrombosis and Haemostasis : JTH·John P Sheehan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.